Status:
COMPLETED
Serum and Uterine Progesterone Levels and ERA Test.
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Conditions:
Endometrial Receptivity
Eligibility:
FEMALE
18-50 years
Brief Summary
Since the implantation is related with endometrial receptivity, the patient specific plasma progesterone concentration influences this pattern. Following this hypothesis, the study establishes a corr...
Detailed Description
In patients who have had problems of assisted reproduction it is essential to establish the factors that contribute to the success of a cycle: correcting these factors means increasing the possibility...
Eligibility Criteria
Inclusion
- Infertile women \<50 years
- One or more failed IVF treatments
- Undergoing an artificial endometrial preparation cycle with hormonal replacement therapy in order to perform an endometrial receptivity analysis through ERA test.
- Endometrial thickness after estrogen treatment \> 6.5 mm with trilaminar structure
Exclusion
- Uterine alterations (fibroids, polyps or Müllerian abnormalities)
- Adnexal pathology
Key Trial Info
Start Date :
March 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2019
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03456375
Start Date
March 13 2018
End Date
March 15 2019
Last Update
April 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI RMA Valencia
Valencia, Spain, 46117